Alembic Pharmaceuticals reports 23% growth in Q2 consolidated net profit

21 Oct 2014 Evaluate

Alembic Pharmaceuticals has reported results for second quarter ended September 30, 2014.

The company has registered 31.67% rise in its net profit at Rs 84.05 crore for the quarter under review as compared to Rs 63.83 crore for the same quarter in the previous year. However, total income of the company has increased 11.54% at Rs 541.52 crore for Q2FY15 as compared Rs 485.46 crore for the corresponding quarter previous year.

On consolidated basis, the company’s net profit after taxes and minority interest for the quarter under review registered 23.35% growth at Rs 77.27 crore against Rs 61.64 crore in the September quarter of previous fiscal. The company’s total income has increased by 12.46% at Rs 547.22 crore for the quarter under review from Rs 486.56 crore in the similar quarter of previous year.

Alembic Pharma Share Price

852.30 -4.95 (-0.58%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×